Calcium pectinate capsules for colon-specific drug delivery

Area of Science:

• Pharmaceutical Sciences
• Drug Delivery Systems
• Colonic Drug Targeting

Background:

• Colon-specific drug delivery is crucial for treating colonic diseases.
• Conventional drug delivery systems often fail to target the colon effectively.
• Developing novel carriers for targeted colonic release remains a significant challenge.

Purpose of the Study:

• To design and develop a novel colon-specific drug delivery system.
• To utilize calcium pectinate (CaP) capsules for targeted delivery of 5-fluorouracil (5-FU).
• To evaluate the in vitro and in vivo performance of the CaP capsule for colon-specific drug release.

Main Methods:

• CaP capsules were fabricated using a dipping method with pectin and calcium chloride solutions.
• In vitro drug release studies were conducted using rat cecal contents.
• Gamma scintigraphy was employed for in vivo tracking and drug release assessment in animal models.
• Biomimic dissolution experiments and studies in healthy volunteers were performed.

Main Results:

• 5-FU release from CaP capsules significantly increased in the presence of rat cecal contents.
• Drug release was influenced by capsule parameters like calcium content, shell thickness, and coat amount.
• Gamma scintigraphy confirmed intact passage through the gastrointestinal tract and drug release in the colon.
• In vitro and human studies validated the colon-specific drug delivery characteristics of the CaP capsule.

Conclusions:

• The developed calcium pectinate (CaP) capsule is an effective colon-specific drug delivery system.
• The CaP capsule demonstrates ideal characteristics for targeted colonic release of 5-fluorouracil.
• This novel system holds promise for improved therapeutic outcomes in colonic diseases.